Snapshot of CGM Metrics in Adolescents and Adults Achieving Target HbA1c Versus Those Not Meeting Target HbA1c

The Australian JDRF Closed-Loop Research Group; Mary B Abraham; Grant J Smith; Janice M Fairchild; Bruce R King; Geoffrey R Ambler; Fergus J Cameron; Sybil A McAuley; Anthony C Keech; Alicia Jenkins; Martin de Bock; Elizabeth A Davis; David N O'Neal; Timothy W Jones

doi:10.1089/dia.2022.0169

Snapshot of CGM Metrics in Adolescents and Adults Achieving Target HbA1c Versus Those Not Meeting Target HbA1c

The Australian JDRF Closed-Loop Research Group, Mary B Abraham, Grant J Smith, Janice M Fairchild, Bruce R King, Geoffrey R Ambler, Fergus J Cameron, Sybil A McAuley, Anthony C Keech, Alicia Jenkins, Martin de Bock, Elizabeth A Davis, David N O'Neal, Timothy W Jones

Paediatrics

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	677-679
Number of pages	3
Journal	Diabetes Technology & Therapeutics
Volume	24
Issue number	9
Early online date	19 Jul 2022
DOIs	https://doi.org/10.1089/dia.2022.0169
Publication status	Published - 1 Sept 2022

Access to Document

10.1089/dia.2022.0169

Cite this

The Australian JDRF Closed-Loop Research Group, Abraham, M. B., Smith, G. J., Fairchild, J. M., King, B. R., Ambler, G. R., Cameron, F. J., McAuley, S. A., Keech, A. C., Jenkins, A., de Bock, M., Davis, E. A., O'Neal, D. N., & Jones, T. W. (2022). Snapshot of CGM Metrics in Adolescents and Adults Achieving Target HbA1c Versus Those Not Meeting Target HbA1c. Diabetes Technology & Therapeutics, 24(9), 677-679. https://doi.org/10.1089/dia.2022.0169

@article{b9ae382955e34fed8e7f3ce2b3eee9f7,

title = "Snapshot of CGM Metrics in Adolescents and Adults Achieving Target HbA1c Versus Those Not Meeting Target HbA1c",

author = "{The Australian JDRF Closed-Loop Research Group} and Abraham, {Mary B} and Smith, {Grant J} and Fairchild, {Janice M} and King, {Bruce R} and Ambler, {Geoffrey R} and Cameron, {Fergus J} and McAuley, {Sybil A} and Keech, {Anthony C} and Alicia Jenkins and {de Bock}, Martin and Davis, {Elizabeth A} and O'Neal, {David N} and Jones, {Timothy W}",

year = "2022",

month = sep,

day = "1",

doi = "10.1089/dia.2022.0169",

language = "English",

volume = "24",

pages = "677--679",

journal = "Diabetes Technology & Therapeutics",

issn = "1557-8593",

publisher = "Mary Ann Liebert Inc",

number = "9",

}

The Australian JDRF Closed-Loop Research Group, Abraham, MB, Smith, GJ, Fairchild, JM, King, BR, Ambler, GR, Cameron, FJ, McAuley, SA, Keech, AC, Jenkins, A, de Bock, M, Davis, EA, O'Neal, DN & Jones, TW 2022, 'Snapshot of CGM Metrics in Adolescents and Adults Achieving Target HbA1c Versus Those Not Meeting Target HbA1c', Diabetes Technology & Therapeutics, vol. 24, no. 9, pp. 677-679. https://doi.org/10.1089/dia.2022.0169

TY - JOUR

T1 - Snapshot of CGM Metrics in Adolescents and Adults Achieving Target HbA1c Versus Those Not Meeting Target HbA1c

AU - The Australian JDRF Closed-Loop Research Group

AU - Abraham, Mary B

AU - Smith, Grant J

AU - Fairchild, Janice M

AU - King, Bruce R

AU - Ambler, Geoffrey R

AU - Cameron, Fergus J

AU - McAuley, Sybil A

AU - Keech, Anthony C

AU - Jenkins, Alicia

AU - de Bock, Martin

AU - Davis, Elizabeth A

AU - O'Neal, David N

AU - Jones, Timothy W

PY - 2022/9/1

Y1 - 2022/9/1

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000829700800001

U2 - 10.1089/dia.2022.0169

DO - 10.1089/dia.2022.0169

M3 - Letter

C2 - 35758719

SN - 1557-8593

VL - 24

SP - 677

EP - 679

JO - Diabetes Technology & Therapeutics

JF - Diabetes Technology & Therapeutics

IS - 9

ER -

Snapshot of CGM Metrics in Adolescents and Adults Achieving Target HbA1c Versus Those Not Meeting Target HbA1c

Access to Document

Other files and links

Jones Improving the Lives of Young People with Type 1 Diabetes using State of the Art Therapies

Cite this

Snapshot of CGM Metrics in Adolescents and Adults Achieving Target HbA1c Versus Those Not Meeting Target HbA1c

Access to Document

Other files and links

Projects

Jones Improving the Lives of Young People with Type 1 Diabetes using State of the Art Therapies

Cite this